Exelixis, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ALNY
|
Alnylam Pharmaceuticals, Inc. | $267.58 | $19.33 B | -57.65 | 2100 | $1.83 B |
 BMRN
|
BioMarin Pharmaceutical Inc. | $65.94 | $15.32 B | 76.12 | 3401 | $2.42 B |
 BTAI
|
BioXcel Therapeutics, Inc. | $0.66 | $53.11 M | -0.27 | 74 | $1.38 M |
 HALO
|
Halozyme Therapeutics, Inc. | $58.07 | $6.47 B | 21.1 | 373 | $829.25 M |
 ICPT
|
Intercept Pharmaceuticals, Inc. | $19.00 | $794.69 M | -17.43 | 341 | $285.71 M |
 KOD
|
Kodiak Sciences Inc. | $4.13 | $151.83 M | -0.65 | 111 | $0 |
 KRYS
|
Krystal Biotech, Inc. | $175.52 | $4.70 B | 75.42 | 229 | $50.70 M |
 MDGL
|
Madrigal Pharmaceuticals, Inc. | $331.72 | $5.21 B | -10.55 | 376 | $0 |
 MRTX
|
Mirati Therapeutics, Inc. | $58.70 | $4.12 B | -4.82 | 587 | $12.44 M |
 PDSB
|
PDS Biotechnology Corporation | $3.29 | $106.92 M | -2.13 | 25 | $0 |
|
PTCT
|
PTC Therapeutics, Inc. | $41.04 | $2.80 B | -4.75 | 988 | $937.82 M |
 RETA
|
Reata Pharmaceuticals, Inc. | $172.36 | $6.57 B | -66.29 | 321 | $2.22 M |
 SGEN
|
Seagen Inc. | $228.74 | $43.15 B | -57.19 | 3256 | $1.96 B |
 SRPT
|
Sarepta Therapeutics, Inc. | $123.21 | $11.66 B | 286.79 | 1314 | $1.24 B |
 TGTX
|
TG Therapeutics, Inc. | $24.39 | $2.45 B | 52.83 | 300 | $233.66 M |
 VKTX
|
Viking Therapeutics, Inc. | $66.04 | $6.17 B | -60.86 | 30 | $0 |
 XFOR
|
X4 Pharmaceuticals, Inc. | $0.54 | $169.62 M | -1.51 | 127 | $0 |